Projects per year
Personal profile
Education
- 2012 Ph.D., Institute of Basic Medical Sciences, National Cheng Kung University.
- 2007 M.S., Department of Physiology, National Cheng Kung University.
- 2004 B.S., Department of Medical Imaging and Radiological Sciences, Central Taiwan University of Science and Technology
Experience
- 2019- Assistant Professor, The Ph.D. Program for Neural Regenerative Medicine, Taipei Medical University
- 2018-2019 Research Assistant, Neuroscience Research Center, Taipei Medical University
- 2017-2019 Research Assistant, The Ph.D.Program for Neural Regenerative Medicine, Taipei Medical University
- 2016-2018 Research Assistant, Center for Neurotrauma and Neuroregeneration, Taipei Medical University
- 2012-2015 Post-Doctor, Center of Infectious Disease and Signal Research, Nationa Cheng Kung University
Awards
- 2014 Excellent Research Award of Post-Doctor by Ministry of Science and Technology.
- 2012 Outstanding Research Award of Medical College in National Cheng Kung University
Research Interests
- Tumor Biology
- Cancer mouse models
Related Link
Fingerprint
Dive into the research topics where Tsung-I Hsu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
粒線體DNA突變相關的脂肪酸代謝重整在神經膠質瘤產生抗藥性中扮演的角色
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
探討神經類固醇用於診斷及治療神經退化性疾病之潛力
3/1/22 → 2/28/23
Project: C - Project of Alliance › o - Chi Mei Medical Center
-
闡明化療對前列腺素E2介導的膠質母細胞瘤和神經元之間交互作用的影響
1/1/22 → 12/31/22
Project: B - Project of TMU › h - Higher Education Sprout Project
-
釐清神經類固醇的代謝在神經膠質瘤的抗藥性中扮演的角色(3/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
異常激活的線粒體呼吸在膠質母細胞瘤抗藥性中的角色
3/1/21 → 2/28/22
Project: C - Project of Alliance › o - Chi Mei Medical Center
-
Allopregnanolone suppresses glioblastoma survival through decreasing DPYSL3 and S100A11 expression
Feng, Y. H., Lim, S. W., Lin, H. Y., Wang, S. A., Hsu, S. P., Kao, T. J., Ko, C. Y. & Hsu, T. I., May 2022, In: Journal of Steroid Biochemistry and Molecular Biology. 219, p. 106067 106067.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
CCAAT/Enhancer-Binding Protein Delta Regulates Glioblastoma Survival through Catalase-Mediated Hydrogen Peroxide Clearance
Lin, H. Y., Lim, S. W., Hsu, T. I., Yang, W. B., Huang, C. C., Tsai, Y. T., Chang, W. C. & Ko, C. Y., 2022, In: Oxidative Medicine and Cellular Longevity. 2022, 4081380.Research output: Contribution to journal › Article › peer-review
Open Access -
HDAC6 involves in regulating the lncRNA-microRNA-mRNA network to promote the proliferation of glioblastoma cells
Wu, A. C., Yang, W. B., Chang, K. Y., Lee, J. S., Liou, J. P., Su, R. Y., Cheng, S. M., Hwang, D. Y., Kikkawa, U., Hsu, T. I., Wang, C. Y., Chang, W. C., Chen, P. Y. & Chuang, J. Y., Dec 2022, In: Journal of Experimental and Clinical Cancer Research. 41, 1, 47.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Regorafenib Reverses Temozolomide-Induced CXCL12/CXCR4 Signaling and Triggers Apoptosis Mechanism in Glioblastoma
Chiang, I. T., Liu, Y. C., Liu, H. S., Ali, A. A. A., Chou, S. Y., Hsu, T. I. & Hsu, F. T., 2022, (Accepted/In press) In: Neurotherapeutics.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation
Tsai, Y. T., Lo, W. L., Chen, P. Y., Ko, C. Y., Chuang, J. Y., Kao, T. J., Yang, W. B., Chang, K. Y., Hung, C. Y., Kikkawa, U., Chang, W. C. & Hsu, T. I., Mar 25 2022, In: Journal of Biomedical Science. 29, 1, p. 21 21.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus)
Datasets
-
MOESM6 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Chuang, J. (Creator), Chen, S. (Contributor), Yang, K. (Creator), Chien, C. (Contributor), Liu, J. (Creator), Hsu, T. (Contributor), Chang, K. (Contributor), Yang, S. (Creator), Chu, J. (Contributor), Chou, S. (Creator), Lo, W. (Creator), Liu, M. (Creator), Huang, C. (Contributor), Yang, W. (Creator), Chen, P. (Contributor) & Chung, P. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.10006874.v1, https://doi.org/10.6084%2Fm9.figshare.10006874.v1
Dataset
-
of A rapid and quantitative method to detect human circulating tumor cells in a preclinical animal model
Lee, C. (Contributor), Chi, W. (Creator), Hsu, T. (Creator), Huang, L. (Contributor), Tu, S. (Contributor), Hsieh, W. (Creator), Hsu, K. (Creator) & Lin, C. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.10038350.v1, https://doi.org/10.6084%2Fm9.figshare.10038350.v1
Dataset
-
MOESM7 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Chou, S. (Creator), Chen, P. (Contributor), Chu, J. (Contributor), Chien, C. (Contributor), Liu, J. (Creator), Liu, M. (Creator), Chuang, J. (Creator), Chung, P. (Contributor), Hsu, T. (Contributor), Chen, S. (Contributor), Yang, S. (Creator), Lo, W. (Creator), Huang, C. (Contributor), Chang, K. (Contributor), Yang, K. (Creator) & Yang, W. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.10006880.v1, https://doi.org/10.6084%2Fm9.figshare.10006880.v1
Dataset
-
Additional file 1: of Suberoylanilide hydroxamic acid represses glioma stem-like cells
Chang, K. (Creator), Wang, J. (Creator), Chuang, J. (Creator), Ko, C. (Contributor), Hsu, T. (Contributor), Chang, W. (Creator), Yeh, S. (Contributor), Liou, J. (Creator), Liu, J. (Contributor) & Hsu, C. (Contributor), Figshare, 2016
DOI: 10.6084/m9.figshare.c.3596465_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3596465_d1.v1
Dataset
-
MOESM1 of Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Yang, K. (Creator), Chen, S. (Contributor), Chung, P. (Contributor), Chang, K. (Contributor), Liu, M. (Creator), Chuang, J. (Creator), Chien, C. (Contributor), Lo, W. (Creator), Hsu, T. (Contributor), Huang, C. (Contributor), Chen, P. (Contributor), Chu, J. (Contributor), Liu, J. (Creator), Yang, S. (Creator), Chou, S. (Creator) & Yang, W. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.10006847.v1, https://doi.org/10.6084%2Fm9.figshare.10006847.v1
Dataset